Life-threatening pneumonitis related to docetaxel chemotherapy

2Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Development of pulmonary infiltrates with respiratory symptoms in patients with advanced cancer presents a diagnostic challenge. We describe a case of a patient who developed progressive respiratory failure and bilateral lung infiltrates whilst receiving docetaxel chemotherapy for advanced lung cancer. After excluding other aetiologies, he was treated for docetaxel-related pneumonitis with corticosteroid therapy. Interstitial pneumonitis is a rare complication of Docetaxel chemotherapy but needs to be recognised and treated early, as it is associated with high mortality rates. We describe the presentation, differential diagnoses and possible mechanisms associated with drug-related pneumonitis.

Cite

CITATION STYLE

APA

Ang, M. K., Lim, D. W. T., Tan, E. H., Ng, Q. S., & Tan, D. S. W. (2015). Life-threatening pneumonitis related to docetaxel chemotherapy. Proceedings of Singapore Healthcare, 24(1), 54–58. https://doi.org/10.1177/201010581502400108

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free